Cyaonoside ACAS# 110081-91-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 110081-91-9 | SDF | Download SDF |
PubChem ID | 102196533.0 | Appearance | Powder |
Formula | C54H86O23 | M.Wt | 1103.25 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxane-2-carboxylic acid | ||
SMILES | CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)CO)O)O)O)OC4CCC5(C(C4(C)C)CCC6(C5CC=C7C6(CCC8(C7CC(CC8)(C)C)C(=O)OC9C(C(C(C(O9)CO)O)O)O)C)C)C)C(=O)O)O)O)O)O | ||
Standard InChIKey | FYCOSNQJVPTNMC-BUCNMUNNSA-N | ||
Standard InChI | InChI=1S/C54H86O23/c1-22-30(57)33(60)36(63)44(70-22)74-40-39(66)41(43(67)68)75-47(42(40)76-45-37(64)34(61)31(58)25(20-55)71-45)73-29-12-13-51(6)27(50(29,4)5)11-14-53(8)28(51)10-9-23-24-19-49(2,3)15-17-54(24,18-16-52(23,53)7)48(69)77-46-38(65)35(62)32(59)26(21-56)72-46/h9,22,24-42,44-47,55-66H,10-21H2,1-8H3,(H,67,68)/t22-,24-,25+,26+,27-,28+,29-,30-,31+,32+,33+,34-,35-,36+,37+,38+,39-,40-,41-,42+,44-,45-,46-,47+,51-,52+,53+,54-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Cyaonoside A Dilution Calculator
Cyaonoside A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.9064 mL | 4.5321 mL | 9.0641 mL | 18.1283 mL | 22.6603 mL |
5 mM | 0.1813 mL | 0.9064 mL | 1.8128 mL | 3.6257 mL | 4.5321 mL |
10 mM | 0.0906 mL | 0.4532 mL | 0.9064 mL | 1.8128 mL | 2.266 mL |
50 mM | 0.0181 mL | 0.0906 mL | 0.1813 mL | 0.3626 mL | 0.4532 mL |
100 mM | 0.0091 mL | 0.0453 mL | 0.0906 mL | 0.1813 mL | 0.2266 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Epipinoresinol-4-O-glucopyranoside
Catalog No.:BCX0750
CAS No.:24404-49-7
- Emetine
Catalog No.:BCX0749
CAS No.:483-18-1
- Yuanhuadine
Catalog No.:BCX0748
CAS No.:76402-66-9
- Kuwanon B
Catalog No.:BCX0747
CAS No.:62949-78-4
- guan-fu base H
Catalog No.:BCX0746
CAS No.:4758-99-0
- Saikosaponin K
Catalog No.:BCX0745
CAS No.:405229-61-0
- Astragenol
Catalog No.:BCX0744
CAS No.:86541-79-9
- Yuanhuacine
Catalog No.:BCX0743
CAS No.:60195-70-2
- Taxifolin 7-O-β-D-glucoside
Catalog No.:BCX0742
CAS No.:14292-40-1
- Edgeworoside C
Catalog No.:BCX0741
CAS No.:126221-40-7
- Lentinan
Catalog No.:BCX0740
CAS No.:37339-90-5
- 6-Methoxyldihydrochelerythrine
Catalog No.:BCX0739
CAS No.:21080-31-9
- Epimedin I
Catalog No.:BCX0752
CAS No.:205445-00-7
- Kuwanon T
Catalog No.:BCX0753
CAS No.:100187-66-4
- luteolin-7-O-gentiobiside
Catalog No.:BCX0754
CAS No.:70855-41-3
- Dihydroferulic acid
Catalog No.:BCX0755
CAS No.:1135-23-5
- Ergothioneine
Catalog No.:BCX0756
CAS No.:497-30-3
- Anemarrhenasaponin A2
Catalog No.:BCX0757
CAS No.:117210-12-5
- Mogroside VI A
Catalog No.:BCX0758
CAS No.:2146088-13-1
- Pulchinenoside E4
Catalog No.:BCX0759
CAS No.:1415553-83-1
- Mogroside VI B
Catalog No.:BCX0760
CAS No.:2149606-17-5
- Oleuropeinic acid
Catalog No.:BCX0761
CAS No.:96382-90-0
- Prosapogenin D
Catalog No.:BCX0762
CAS No.:103629-72-7
- 3,4'-Dihydroxyflavone
Catalog No.:BCX0763
CAS No.:14919-49-4
Cyaonoside A-loaded composite hydrogel microspheres to treat osteoarthritis by relieving chondrocyte inflammation.[Pubmed:38591180]
J Mater Chem B. 2024 Apr 9.
Cyaonoside A (CyA), derived from the natural Chinese medicine, Cyathula officinalis Kuan, which was for a long time used to treat knee injuries and relieve joint pain in traditional Chinese medicine, showed an unclear mechanism for protecting cartilage. In addition, CyA was poorly hydrosoluble and incapable of being injected directly into the joint cavity, which limited its clinical application. This study reveals that CyA resisted IL-1beta-mediated chondrogenic inflammation and apoptosis. Next, transcriptome sequencing is used to explore the potential mechanisms underlying CyA regulation of MSC chondrogenic differentiation. Based on these findings, CyA-loaded composite hydrogel microspheres (HLC) were developed and they possessed satisfactory loading efficiency, a suitable degradation rate and good biocompatibility. HLC increased chondrogenic anabolic gene (Acan, COL2A, and SOX9) expression, while downregulating the expression of the catabolic marker MMP13 in vitro. In the osteoarthritis mouse model, HLC demonstrated promising therapeutic capabilities by protecting the integrity of articular cartilage. In conclusion, this study provides insights into the regulatory mechanisms of CyA for chondrocytes and proposes a composite hydrogel microsphere-based advanced therapeutic strategy for osteoarthritis.